Core Insights - Adia Nutrition Inc. has received approval from the independent Institutional Review Board (IRB) BeyondBound for a clinical study focused on Autism Spectrum Disorder (ASD) [1][5] - The study will enroll 100 children aged 3-12 to evaluate the effectiveness of combining glutathione with umbilical cord blood-derived stem cells compared to glutathione alone [2][5] - Patient recruitment is set to begin in January 2026, with updates on enrollment and study progress to be provided regularly [4] Study Details - The clinical study is titled "Adia Med of Winter Park LLC Autism Spectrum Disorder Research Study" and aims to measure improvements in social interaction, communication, behavior, and overall quality of life for children with ASD [2][5] - The study details have been submitted to ClinicalTrials.gov and are in the final review stage before public visibility [3] Company Overview - Adia Nutrition Inc. is based in Winter Park, Florida, and specializes in regenerative medicine through its Adia Med subsidiary, focusing on stem cell and regenerative products [7][8] - The company generates revenue through service fees, product sales, equity stakes, and insurance billing for healthcare treatments [8] - Adia Nutrition is expanding its operations with Adia Med clinics that offer various regenerative therapies, including stem cell therapies and advanced treatments [7][8] Future Plans - The autism study will serve as a foundational model for additional clinical studies planned for 2026 targeting various other conditions [5] - The company is open to strategic partnerships with clinic owners and healthcare practitioners interested in integrating Adia's regenerative therapies into their practices [6]

Research Focus - Autism may not be a single condition, but several [1] - Research into the spectrum's diversity could lead to better treatments and interventions [1]

Autism Research & Treatment - Research suggests autism may not be a single condition, but multiple conditions [1] - Understanding the diversity within the autism spectrum could lead to improved treatments and interventions [1]